Zetogain Tablet contains Alpha Ketoanalogue (NA), a specialized nutritional supplement primarily indicated for patients with chronic kidney disease (CKD) to help manage protein intake while minimizing nitrogenous waste accumulation. Alpha Ketoanalogues serve as nitrogen-free analogues of essential amino acids, facilitating the synthesis of amino acids without contributing to the nitrogen load, thereby reducing uremic toxin production. Zetogain is typically prescribed as an adjunct to a low-protein diet to slow the progression of renal impairment and delay the need for dialysis. The tablet aids in maintaining a balanced nitrogen metabolism, improving nutritional status, and reducing the risk of protein-energy malnutrition commonly observed in CKD patients. Clinical use of Zetogain requires careful dietary supervision and regular monitoring of renal function and nutritional parameters. It is contraindicated in patients with hypersensitivity to any component of the formulation. Common side effects are rare but may include gastrointestinal discomfort or allergic reactions. Zetogain should be used under medical supervision, with dosage adjustments tailored to individual patient needs and renal function status. This product supports renal health by optimizing amino acid availability while mitigating the metabolic burden on compromised kidneys.